Codon Devices, the Cambridge, MA-based company working on commercial uses of synthetic biology, said today it has formed a multi-year partnership with Naples, FL-based Algenol Biofuels to work on alternative fuel made from algae. Codon will offer its BioLogic protein engineering techniques to the collaboration, which it has begun emphasizing as part of a new strategy we wrote about last month. Financial terms of the new agreement weren’t disclosed.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
